Panacea Biotec terminates MoU with Refana for COVID-19 vaccine EP News Bureau Aug 23, 2020 The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint…
Roll-out plan of Sputnik-V prompts worries about virus mutation Reuters Aug 22, 2020 Viruses are known for their ability to mutate all the time - and often this has little or no impact on the risk posed to people
40 per cent participants enrolled for COVID-19 vaccine trial: Moderna Reuters Aug 22, 2020 Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September
EU, CureVac may sign deal for 225 million doses of COVID-19 vaccine Reuters Aug 20, 2020 CureVac said it could start large-scale human trials on its vaccine in the last quarter of this year based on results of its…
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR Press Trust of India Aug 20, 2020 Normally the final trial takes about six to nine months
WHO cautions against to ‘vaccine nationalism’ Reuters Aug 19, 2020 Urges all members to join COVAX vaccine effort
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate Reuters Aug 18, 2020 The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil
India in talks with developer of Russian COVID-19 vaccine: The Indian Express EP News Bureau Aug 18, 2020 Russian regulators recently approved the Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and…
Race to find a viable vaccine: Can Indian firms rise to the challenge? EP News Bureau Aug 17, 2020 Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…
CanSino gets COVID-19 vaccine patent from China’s IP regulator Reuters Aug 17, 2020 As per reports by state media the patent was issued on August 11